Global Intravenous Solution Market, By Product (Isotonic Solutions, Hypotonic Solutions, Hypertonic Solutions) By Composition (9% Normal Saline, Lactated Ringers, 5% Dextrose in Water, Others) By Distribution Channel (Hospital Pharmacies, Drug Stores, Retail Pharmacies), and opportunities and forecast 2023-2030

Intravenous Solution Market Overview

In clinical medicine, intravenous solutions are commonly used to restore and maintain body fluids. They are given to people who have lost body fluids owing to dehydration or other medical conditions. Intravenous solutions are injected straight into the veins and provide immediate relief to those undergoing treatment. The global Intravenous Solution market is projected to rise at a significant rate in the forecast period.

Increased incidence of chronic and acute diseases, rise in the geriatric population, increase in strategic collaborations between manufacturers to enhance their product portfolio and geographical presence, expansion in the pharmaceutical industry, increase in demand for intravenous solutions from developing economies, and increase in health care expenditure are all major drivers of the global intravenous solutions market.

On the negative side, the global intravenous solution market is expected to be restrained over the forecast period due to factors such as a strict regulatory environment and high fluid maintenance costs.

Report Metric	Details
Market size available for years	2019–2027
Base year considered	2019
Forecast period	2020–2027
Forecast unit	Value (USD Million)
Segments covered	Product, Composition, Distribution Channel, and Region.
Regions covered	North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA)
Companies covered	Baxter, Fresenius Kabi, B. Braun Melsungen AG, ICU Medical, Inc., Grifols S.A, Pfizer.

Covid-19 Impact on Intravenous Solution Market
 
In addition, the current Intravenous Solution Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Intravenous Solution Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.

Intravenous Solution Market Segment Overview


According to Product, Isotonic Solutions is one of the largest segments in the global Intravenous Solution market. There are several types of intravenous solutions on the market, including isotonic, hypertonic, and hypotonic. Isotonic solutions are made up of normal saline (0.9 NaCl) and are used to replace the extracellular fluid in the treatment of hypernatremia. As electrolyte replenishers, hypotonic intravenous solutions with 0.45 percent NaCl are utilized. Hypotonic solutions are used to treat dilutional hypernatremia and low sodium levels in severe situations.
 
Intravenous Solution Market, By Product
·       Isotonic Solutions
·       Hypotonic Solutions
·       Hypertonic Solutions

Intravenous Solution Market, By Composition
·       9% Normal Saline
·       Lactated Ringers
·       5% Dextrose in Water
·       Others

Intravenous Solution Market, By Distribution Channel
·       Hospital Pharmacies
·       Drug Stores
·       Retail Pharmacies

Intravenous Solution Regional Overview

Based on the region, the intravenous solution market in North America is expected to dominate the global market, followed by the intravenous solution market in Europe during the projected period. Increased incidence of chronic diseases, increased demand for intravenous solutions, and the presence of key manufacturers in the region are the major factors leading to the dominance of the two regions in the global intravenous solution market. During the forecast period, the market in the Asia Pacific is expected to create attractive prospects for manufacturers. Due to an increase in the patient population, the rapid expansion of the pharmaceutical industry in the region increased mergers and acquisitions, and increased government initiatives to promote better health care facilities in the region's developing economies, the market in the region is expected to grow at a rapid pace.

Intravenous Solution Market, By Geography

·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
  
Intravenous Solution Market, Key Players

·       Baxter
·       Fresenius Kabi
·       B. Braun Melsungen AG
·       ICU Medical, Inc.
·       Grifols S.A
·       Pfizer
·       other

Frequently Asked Questions (FAQ) :

Q1. What are the driving factors for the global Intravenous Solution market?

Q2. What are the restraining factors for the global Intravenous Solution market?

Q3. Which segment is projected to hold the largest share in the global Intravenous Solution Market?

Q4. Which region holds the largest share in the global Intravenous Solution market?

Q5. Which are the prominent players in the global Intravenous Solution Market?